EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fingolimod improves diffuse brain injury by promoting AQP4 polarization and functional recovery of the glymphatic system

Dongyi Feng, Tao Liu, Xinjie Zhang, Tangtang Xiang, Wanqiang Su, Wei Quan, Rongcai Jiang iD

CNS Neuroscience & Therapeutics · 2024-03 · 30 (3)

DOI: 10.1111/cns.14669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 08.03.2024. Verfasst von Dongyi Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Glymphatic System, Brain Edema, Encephalitis, Brain Injuries, Diffuse. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The National Natural Science Foundation of China, The Clinical Study of Tianjin Medical University, Tianjin Research Program of Application Foundation and Advanced Technology of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diffuse brain injury (DBI) models are characterized by intense global brain inflammation and edema, which characterize the most severe form of TBI. In a previous experiment, we found that fingolimod promoted recovery after controlled cortical impact injury (CCI) by modulating inflammation around brain lesions. However, it remains unclear whether fingolimod can also attenuate DBI because of its different injury mechanisms. Furthermore, whether fingolimod has additional underlying effects on repairing DBI is unknown.

Methods

The impact acceleration model of DBI was established in adult Sprague–Dawley rats. Fingolimod (0.5 mg/kg) was administered 0.5, 24, and 48 h after injury for 3 consecutive days. Immunohistochemistry, immunofluorescence analysis, cytokine array, and western blotting were used to evaluate inflammatory cells, inflammatory factors, AQP4 polarization, apoptosis in brain cells, and the accumulation of APP after DBI in rats. To evaluate the function of the glymphatic system (GS), a fluorescent tracer was injected into the cistern. The neural function of rats with DBI was evaluated using various tests, including the modified neurological severity score (mNSS), horizontal ladder‐crossing test, beam walking test, and tape sensing and removal test. Brain water content was also measured.

Results

Fingolimod administration for 3 consecutive days could reduce the levels of inflammatory cytokines, neutrophil recruitment, microglia, and astrocyte activation in the brain following DBI. Moreover, fingolimod reduced apoptotic protein expression, brain cell apoptosis, brain edema, and APP accumulation. Additionally, fingolimod inhibited the loss of AQP4 polarization, improved lymphatic system function, and reduced damage to nervous system function. Notably, inhibiting the GS weakened the therapeutic effect of fingolimod on the neurological function of rats with DBI and increased the accumulation of APP in the brain.

Conclusions

In brief, these findings suggest that fingolimod alleviates whole‐brain inflammation and GS system damage after DBI and that inhibiting the GS could weaken the positive effect of fingolimod on nerve function in rats with DBI. Thus, inhibiting inflammation and regulating the GS may be critical for the therapeutic effect of fingolimod on DBI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glymphatic SystemBrain EdemaEncephalitisBrain Injuries, DiffuseBrain Injuries, TraumaticRatsAnimalsFingolimod HydrochlorideRats, Sprague-DawleyCytokinesInflammationDisease Models, Animal

Stichwörter der Autor:innen

AQP4cytokine arraydiffuse brain injuryfingolimodglymphatic systemimmunoinflammatory response

Substanzen

Fingolimod HydrochlorideCytokines

Autor:innen und Institutionen

  • Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Tianjin Neurological Institute, Key Laboratory of Post Neuro-injury Neuro-repair and Regeneration in Central Nervous System, State Key Laboratory of Experimental Hematology, Ministry of Education, Tianjin, China.

ORCID-Profile: Rongcai Jiang

Förderung

  • The National Natural Science Foundation of China
  • The Clinical Study of Tianjin Medical University
  • Tianjin Research Program of Application Foundation and Advanced Technology of China
  • National Natural Science Foundation of Tianjin
  • National Natural Science Foundation of China

Zitieren

APA

Feng, D., Liu, T., Zhang, X., Xiang, T., Su, W., Quan, W., & Jiang, R. (2024). Fingolimod improves diffuse brain injury by promoting AQP4 polarization and functional recovery of the glymphatic system. CNS Neuroscience & Therapeutics, 30(3). https://doi.org/10.1111/cns.14669

Vancouver

Feng D, Liu T, Zhang X, Xiang T, Su W, Quan W, et al. Fingolimod improves diffuse brain injury by promoting AQP4 polarization and functional recovery of the glymphatic system. CNS Neuroscience & Therapeutics. 2024;30(3). doi:10.1111/cns.14669

BibTeX
@article{Feng2024,
  author = {Feng, Dongyi and Liu, Tao and Zhang, Xinjie and Xiang, Tangtang and Su, Wanqiang and Quan, Wei and Jiang, Rongcai},
  title = {Fingolimod improves diffuse brain injury by promoting AQP4 polarization and functional recovery of the glymphatic system},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  volume = {30},
  number = {3},
  doi = {10.1111/cns.14669}
}
Kostenlos starten →